Professor Kevin Pfleger is Director of the WA Life Sciences Innovation Hub at The University of Western Australia (UWA) and Head of Molecular Endocrinology and Pharmacology at UWA’s Centre for Medical Research (Harry Perkins Institute of Medical Research). His laboratory studies the molecular pharmacology of receptors, particularly those important in kidney disorders, cardiovascular disease, diabetes complications and cancer. He is also Chief Scientific Advisor of ASX-listed Dimerix Limited. Prof Pfleger is Chair of the Executive Committee of Accelerating Australia, serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), and is a member of the International Advisory Group of the British Pharmacological Society. He has won numerous awards for his work and service, most recently from ASCEPT for his outstanding contribution and leadership as Chair of the Scientific Advisory Committee 2017-2018.
Abstracts this author is presenting: